DVYSR.ST | Devyser Diagnostics AB (publ) Annual &

Annual Balance Sheets

(In SEK)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	510.1 Million	500.63 Million	456.86 Million	74.35 Million	73.7 Million	48.22 Million
Total Current Assets	341.8 Million	412.1 Million	412.65 Million	39.69 Million	32.43 Million	27.84 Million
Cash And Short Term Investments	262.89 Million	363.6 Million	377.63 Million	8.34 Million	10.37 Million	7.53 Million
Cash and Cash Equivalents	262.89 Million	363.6 Million	377.63 Million	8.34 Million	10.37 Million	7.53 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	45.3 Million	33.38 Million	26.16 Million	25.13 Million	17.18 Million	15.28 Million
Inventory	20.6 Million	10.28 Million	6.94 Million	5.44 Million	3.86 Million	4.12 Million
Other Current Assets	13 Million	4.84 Million	1.9 Million	772 Thousand	1 Million	897 Thousand
Total Non-Current Assets	168.3 Million	88.52 Million	44.21 Million	34.66 Million	41.26 Million	20.38 Million
Net PPE	91.5 Million	30.5 Million	16.69 Million	15.53 Million	18.21 Million	3.74 Million
Good Will And Intangible Assets	56.1 Million	39.8 Million	18.25 Million	14.41 Million	20.47 Million	-
Good Will	6.7 Million	6.76 Million	236 Thousand	236 Thousand	-	-
Intangible Assets	49.4 Million	33 Million	18.01 Million	14.18 Million	-	-
Long-Term Investments	100 Thousand	89 Thousand	2.05 Million	159 Thousand	128 Thousand	-
Tax Assets	20.6 Million	18.28 Million	7.21 Million	4.55 Million	2.45 Million	1.7 Million
Other Non Current Assets	-	-149 Thousand	1000.00	-1001.00	-1000.00	14.92 Million
Other Assets	-	-	-	1.00	2.00	-
Total Liabilities	125 Million	69.19 Million	40.18 Million	43.58 Million	36.69 Million	18.25 Million
Total Current Liabilities	62.9 Million	51.23 Million	29.42 Million	28.02 Million	15.88 Million	9.74 Million
Account Payables	14.2 Million	9.6 Million	9.66 Million	6.34 Million	3.4 Million	3.16 Million
Tax Payables	300 Thousand	3.05 Million	654 Thousand	1.98 Million	3.25 Million	-
Short Term Debt	17.5 Million	5.52 Million	3 Million	6.49 Million	3.47 Million	1.34 Million
Deferred Revenue	300 Thousand	3.05 Million	234 Thousand	1.98 Million	3.25 Million	-
Other Current Liabilities	30.9 Million	33.05 Million	16.52 Million	13.21 Million	5.74 Million	5.23 Million
Total Non Current Liabilities	62.1 Million	17.95 Million	10.75 Million	15.55 Million	20.81 Million	8.5 Million
Long-Term Debt	600 Thousand	555 Thousand	9.96 Million	4.22 Million	7.5 Million	7.56 Million
Deferred Revenue Non Current	56.7 Million	15.12 Million	-	-	-	812.99 Thousand
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	4.6 Million	1.94 Million	797 Thousand	11.33 Million	13.3 Million	129 Thousand
Other Liabilities	-	-	-	-	-	1.00
Total Equity	385.1 Million	431.44 Million	416.68 Million	30.77 Million	37.01 Million	29.96 Million
Stock Holders Equity	385.1 Million	431.44 Million	416.68 Million	30.77 Million	37.01 Million	29.96 Million
Common Stock	900 Thousand	925 Thousand	872 Thousand	500 Thousand	290 Thousand	290 Thousand
Retained Earnings	-130.19 Million	-77.94 Million	-33.02 Million	-12.36 Million	-1.43 Million	-8.44 Million
Accumulated other comprehensive income	1.2 Million	844 Thousand	-440 Thousand	-451 Thousand	-267 Thousand	-162 Thousand
Common Stock Equity	385.1 Million	431.44 Million	416.68 Million	30.77 Million	37.01 Million	29.96 Million
Capital Lease Obligation	56.7 Million	15.12 Million	9.96 Million	10.78 Million	12.88 Million	813 Thousand
Total Investments	100 Thousand	89 Thousand	2.05 Million	159 Thousand	128 Thousand	-
Total Debt	74.8 Million	21.2 Million	12.96 Million	21.5 Million	23.86 Million	9.72 Million
Net Debt	-188.09 Million	-342.39 Million	-364.67 Million	13.15 Million	13.49 Million	2.18 Million

Breakdown	2024 Q3	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3
Total Assets	462.9 Million	489.8 Million	496.6 Million	510.1 Million	510.1 Million	522.5 Million
Total Current Assets	258.89 Million	295.1 Million	306 Million	341.8 Million	341.8 Million	363.1 Million
Cash And Short Term Investments	171.4 Million	201 Million	215 Million	262.89 Million	262.89 Million	287.9 Million
Cash and Cash Equivalents	171.4 Million	201 Million	215 Million	262.89 Million	262.89 Million	287.9 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	49.5 Million	49.2 Million	52.4 Million	45.3 Million	45.3 Million	46.7 Million
Inventory	24.6 Million	26.3 Million	24.6 Million	20.6 Million	20.6 Million	15.7 Million
Other Current Assets	13.39 Million	18.6 Million	14 Million	13 Million	13 Million	12.8 Million
Total Non-Current Assets	204 Million	194.7 Million	190.6 Million	168.3 Million	168.3 Million	159.39 Million
Net PPE	100 Million	102 Million	103.9 Million	91.5 Million	91.5 Million	90.5 Million
Good Will And Intangible Assets	82.9 Million	71.5 Million	65.8 Million	56.1 Million	56.1 Million	50.3 Million
Good Will	6.8 Million	6.9 Million	7 Million	6.7 Million	6.7 Million	7 Million
Intangible Assets	76.1 Million	64.6 Million	58.8 Million	49.4 Million	49.4 Million	43.3 Million
Long-Term Investments	200 Thousand	200 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand
Tax Assets	20.9 Million	20.9 Million	20.8 Million	20.6 Million	20.6 Million	18.6 Million
Other Non Current Assets	-	100 Thousand	-	-	-	-100 Thousand
Other Assets	1.00	-	-	-	-	1.00
Total Liabilities	114.1 Million	121.9 Million	123.1 Million	125 Million	125 Million	124.3 Million
Total Current Liabilities	61.5 Million	67.09 Million	64.9 Million	62.9 Million	62.9 Million	52.2 Million
Account Payables	10.1 Million	15 Million	17.2 Million	14.2 Million	14.2 Million	10.3 Million
Tax Payables	-	600 Thousand	700 Thousand	300 Thousand	300 Thousand	3 Million
Short Term Debt	13.7 Million	14.7 Million	16 Million	17.5 Million	17.5 Million	5.8 Million
Deferred Revenue	-	599.99 Thousand	700 Thousand	300 Thousand	300 Thousand	3 Million
Other Current Liabilities	37.7 Million	36.8 Million	31 Million	30.9 Million	30.9 Million	33.1 Million
Total Non Current Liabilities	52.59 Million	54.8 Million	58.19 Million	62.1 Million	62.1 Million	72.1 Million
Long-Term Debt	400 Thousand	400 Thousand	400 Thousand	600 Thousand	600 Thousand	500 Thousand
Deferred Revenue Non Current	-400 Thousand	49.7 Million	51.89 Million	56.7 Million	56.7 Million	67.8 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	52.39 Million	4.5 Million	4.7 Million	4.6 Million	4.6 Million	3.6 Million
Other Liabilities	1.00	1.00	1.00	-	-	-
Total Equity	349 Million	367.9 Million	374.5 Million	385.1 Million	385.1 Million	398.1 Million
Stock Holders Equity	349 Million	367.9 Million	374.5 Million	385.1 Million	385.1 Million	398.1 Million
Common Stock	900 Thousand	900 Thousand	900 Thousand	900 Thousand	900 Thousand	900 Thousand
Retained Earnings	-187 Million	-164.5 Million	-142 Million	-130.19 Million	-130.19 Million	-117.4 Million
Accumulated other comprehensive income	2.5 Million	1.2 Million	1.7 Million	1.2 Million	1.2 Million	1.4 Million
Common Stock Equity	349 Million	367.9 Million	374.5 Million	385.1 Million	385.1 Million	398.1 Million
Capital Lease Obligation	-	49.7 Million	51.9 Million	56.7 Million	56.7 Million	67.8 Million
Total Investments	200 Thousand	200 Thousand	100 Thousand	100 Thousand	100 Thousand	100 Thousand
Total Debt	13.7 Million	64.8 Million	68.3 Million	74.8 Million	74.8 Million	74.1 Million
Net Debt	-157.7 Million	-136.2 Million	-146.7 Million	-188.09 Million	-188.09 Million	-213.8 Million

Balance Sheet Charts

Moriya Corporation

1798

Full Analysis

Annual Balance Sheets
Newmax Technology Co., Ltd.

3630

Full Analysis

Annual Balance Sheets
Semba Tohka Industries Co., Ltd

2916

Full Analysis

Annual Balance Sheets
Altex Industries, Inc.

ALTX

Full Analysis

Annual Balance Sheets
Avricore Health Inc.

AVCRF

Full Analysis

Annual Balance Sheets
PsyBio Therapeutics Corp.

PSYBF

Full Analysis

Annual Balance Sheets

Global Stocks Search

Devyser Diagnostics AB (publ) (DVYSR.ST)

Annual Balance Sheets

Balance Sheet Charts

Moriya Corporation

Newmax Technology Co., Ltd.

Semba Tohka Industries Co., Ltd

Altex Industries, Inc.

Avricore Health Inc.

PsyBio Therapeutics Corp.